Short answer · Medically reviewed summary · Last updated: 2026-04-07
Dermatomyositis and polymyositis are generally considered autoimmune conditions rather than strictly hereditary diseases, meaning they are not passed down through a simple Mendelian inheritance pattern. While there is a documented genetic predisposition that increases susceptibility, the development of these conditions typically involves a complex interplay between genetic risk factors and environmental triggers. Is Dermatomyositis and Polymyositis considered hereditary? In the clinical field, we distinguish between "hereditary" diseases—which are caused by a single gene mutation passed directly from parent to child—and "multifactorial" conditions like Dermatomyositis and Polymyositis.
Dermatomyositis and polymyositis are generally considered autoimmune conditions rather than strictly hereditary diseases, meaning they are not passed down through a simple Mendelian inheritance pattern. While there is a documented genetic predisposition that increases susceptibility, the development of these conditions typically involves a complex interplay between genetic risk factors and environmental triggers.
In the clinical field, we distinguish between "hereditary" diseases—which are caused by a single gene mutation passed directly from parent to child—and "multifactorial" conditions like Dermatomyositis and Polymyositis. These conditions are not caused by one specific gene mutation; therefore, they do not follow an autosomal dominant, recessive, or X-linked inheritance pattern. Instead, research suggests that individuals may inherit a genetic predisposition that makes their immune system more likely to react inappropriately to external triggers, such as viral infections, UV exposure, or certain medications. Because of this, it is very rare to see multiple generations of a family affected by Dermatomyositis and Polymyositis.
The genetic architecture of Dermatomyositis and Polymyositis is primarily associated with the Human Leukocyte Antigen (HLA) region on chromosome 6. This region is critical for the immune system to recognize "self" versus "foreign" invaders. Specific HLA alleles have been identified that correlate with an increased risk for developing these inflammatory myopathies. However, carrying these risk alleles does not guarantee that a person will develop the disease. Because these conditions are considered multifactorial, de novo (spontaneous) mutations are not the primary driver of disease onset, and there is no simple "test" to determine if a child will inherit the disease from an affected parent.
Currently, routine genetic testing is not used to diagnose Dermatomyositis and Polymyositis or to predict the risk for family members. Because the condition is not caused by a single gene, there is no standardized "carrier test" or prenatal diagnostic tool available. If you have been diagnosed with Dermatomyositis and Polymyositis, you may wonder about the risk to your future children. Based on current clinical data, the absolute risk of an affected parent passing the condition to a child is very low, as the disease is not inherited in a direct, predictable way.
While standard genetic testing is not typically indicated, meeting with a genetic counselor can still be valuable for patients with Dermatomyositis and Polymyositis who are concerned about family history. A counselor can help by:
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.